Cargando…
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)
BACKGROUND: Current guidelines on the management of urinary tract infection recommend treating febrile urinary tract infection or acute pyelonephritis with antimicrobials for at least 14 days. Few randomized trials showed the effectiveness of treatment durations of 5 to 7 days but this has only been...
Autores principales: | van Nieuwkoop, Cees, van't Wout, Jan W, Assendelft, Willem JJ, Elzevier, Henk W, Leyten, Eliane MS, Koster, Ted, Wattel-Louis, G Hanke, Delfos, Nathalie M, Ablij, Hans C, Kuijper, Ed J, Pander, Jan, Blom, Jeanet W, Spelt, Ida C, van Dissel, Jaap T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733899/ https://www.ncbi.nlm.nih.gov/pubmed/19691829 http://dx.doi.org/10.1186/1471-2334-9-131 |
Ejemplares similares
-
Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study
por: van Nieuwkoop, Cees, et al.
Publicado: (2010) -
Diabetes and the Course of Febrile Urinary Tract Infection
por: van der Starre, Willize E., et al.
Publicado: (2013) -
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women
por: van Nieuwkoop, Cees, et al.
Publicado: (2017) -
Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule
por: Stalenhoef, Janneke E., et al.
Publicado: (2017) -
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
por: Stalenhoef, Janneke Evelyne, et al.
Publicado: (2019)